FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 51 through 100 of 161

PHARMACEUTICAL PREPARATIONS - SIC # 2834

Ticker Exchange Company Financial Reports SIC #
GDTC Nasdaq CytoMed Therapeutics Limited 2834
GHRS Nasdaq GH Research PLC 2834
GLTO Nasdaq Galecto, Inc. 2834
GNFT Nasdaq Genfit S.A. 2834
GNTA Nasdaq Genenta Science S.p.A. 2834
GRCE Nasdaq Grace Therapeutics, Inc. 2834
GRI Nasdaq GRI Bio, Inc. 2834
GSK New York GSK plc 2834
HLN New York Haleon plc 2834
HLVX Nasdaq HilleVax, Inc. 2834
IBIO NYSE American iBio, Inc. 2834
IDYA Nasdaq IDEAYA Biosciences, Inc. 2834
IMMX Nasdaq Immix Biopharma, Inc. 2834
IMRN Nasdaq Immuron Limited 2834
INVA Nasdaq Innoviva, Inc. 2834
IOBT Nasdaq IO Biotech, Inc. 2834
ITCI Nasdaq Intra-Cellular Therapies, Inc. 2834
ITRM Nasdaq Iterum Therapeutics plc 2834
JAGX Nasdaq Jaguar Health, Inc. 2834
JANX Nasdaq Janux Therapeutics, Inc. 2834
JUNS Nasdaq Jupiter Neurosciences, Inc. 2834
KAPA NYSE American Kairos Pharma, Ltd. 2834
KPRX Nasdaq Kiora Pharmaceuticals, Inc. 2834
KPTI Nasdaq Karyopharm Therapeutics Inc. 2834
KROS Nasdaq Keros Therapeutics, Inc. 2834
KZIA Nasdaq Kazia Therapeutics Limited 2834
LCTX NYSE American Lineage Cell Therapeutics, Inc. 2834
LEXX Nasdaq Lexaria Bioscience Corp. 2834
LXEO Nasdaq Lexeo Therapeutics, Inc. 2834
LYRA Nasdaq Lyra Therapeutics, Inc. 2834
MAIA NYSE American MAIA Biotechnology, Inc. 2834
MBRX Nasdaq Moleculin Biotech, Inc. 2834
MIRA Nasdaq MIRA Pharmaceuticals, Inc. 2834
MLTX Nasdaq MoonLake Immunotherapeutics 2834
MREO Nasdaq Mereo BioPharma Group plc 2834
MRK New York Merck & Co., Inc. 2834
MTVA Nasdaq MetaVia Inc. 2834
MURA Nasdaq Mural Oncology plc 2834
MXCT Nasdaq MaxCyte, Inc. 2834
NBIX Nasdaq Neurocrine Biosciences, Inc. 2834
NKTR Nasdaq Nektar Therapeutics 2834
NKTX Nasdaq Nkarta, Inc. 2834
NMRA Nasdaq Neumora Therapeutics, Inc. 2834
NVAX Nasdaq Novavax, Inc. 2834
NVCT Nasdaq Nuvectis Pharma, Inc. 2834
NVS New York Novartis AG 2834
OCS Nasdaq Oculis Holding AG 2834
OCUL Nasdaq Ocular Therapeutix, Inc. 2834
OMER Nasdaq Omeros Corporation 2834
OPT Nasdaq Opthea Limited 2834
Results 50 through 100 of 161